FILING DEADLINE–Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of SVXY, UXIN, TAP and CVS – iCrowdNewswire
Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

Mar 6, 2019 6:50 AM ET

FILING DEADLINE–Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of SVXY, UXIN, TAP and CVS


FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of SVXY, UXIN, TAP and CVS

Legal Newswire

iCrowd Newswire - Mar 6, 2019

CEDARHURST, N.Y.,  — The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses.

If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the respective securities during the class periods. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No classes have yet been certified in the actions below. Appointment as lead plaintiff is not required to partake in any recovery.

ProShares Short VIX Short-Term Futures (NYSEArca: SVXY)
Investors Affected: Investors in ProShares Short VIX Short-Term Futures ETF pursuant to the May 15, 2017 Registration Statement and/or between May 15, 2017 and February 5, 2018

A class action has commenced on behalf of certain investors in ProShares Short VIX Short-Term Futures. According to the complaint in the Registration Statement and during the Class Period, defendants made false and misleading statements and/or failed to disclose adverse information regarding the risks of investing in the Fund. Specifically, the Registration Statement failed to disclose that the Fund was threatened with catastrophic losses as a result of the Fund’s flawed design and the low-volatility environment and acute liquidity risks that existed during the Class Period. In addition, during the Class Period defendants made similar false and misleading statements in numerous financial reports and draft prospectuses and registration statements filed with the SEC.

Shareholders may find more information at https://kseclaw.com/securities/proshares-short-vix-short-term-futures-loss-submission-form/?wire=3

Uxin Limited (NASDAQGS: UXIN)
Investors Affected: Pursuant and/or traceable to the Company’s Registration Statement and Prospectus issued in connection with the June 27, 2018 initial public offering

A class action has commenced on behalf of certain shareholders in Uxin Limited. The Registration Statement was materially false and misleading and omitted to state that: (1) Uxin was likely to stop providing complementary services such as inspections to its customers; (2) instead, Uxin would connect consumers to dealers who would provide such complementary services; (3) as a result, Uxin’s 2B business would be materially impacted; and (4) consequently, Defendants’ statements in the Registration Statement regarding Uxin’s business, operations, and prospects, were materially false and/or misleading.

Shareholders may find more information at https://kclasslaw.com/securities/uxin-limited-loss-submission-form/?wire=3

Molson Coors Brewing Company (NYSE: TAP)
Investors Affected: February 14, 2017 – February 12, 2019

A class action has commenced on behalf of certain shareholders in Molson Coors Brewing Company. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Molson Coors failed to properly reconcile the outside basis deferred income tax liability for Molson Coors’ investment in its MillerCoors, LLC partnership; (2) consequently, Molson Coors misreported net income in its consolidated financial statements for the fiscal years ending December 31, 2016 and December 31, 2017, resulting in an overall downward revision to net income; (3) Molson Coors lacked adequate internal controls over financial reporting; and (4) as a result, defendants’ statements about Molson Coors’ business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Shareholders may find more information at https://kclasslaw.com/securities/molson-coors-brewing-company-loss-submission-form/?wire=3

CVS Health Corporation (NYSE: CVS)
Investors Affected: May 21, 2015 – February 20, 2019

A class action has commenced on behalf of certain shareholders in CVS Health Corporation. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) CVS Health’s financial condition and expected earnings were deteriorating as a result of rising costs and poor results associated with the Omnicare Acquisition; and (ii) as a result, CVS Health’s public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://kclasslaw.com/securities/cvs-health-corporation-loss-submission-form/?wire=3

Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company’s stock.

Contact Information:

Kuznicki Law PLLC
Daniel Kuznicki, Esq.
445 Central Avenue, Suite 344
Cedarhurst, NY 11516
Email: [email protected]
Phone: (347) 696-1134
Cell: (347) 690-0692
Fax: (347) 348-0967








Tags:    Wire, Legal Newswire, United States, English